Pear Therapeutics and Sandoz Announce Deal to Commercialize Prescription Digital Therapeutics
Pear Therapeutics, Inc. today announced a deal with Sandoz, a division of Novartis, to commercialize…
Arboretum_JDApril 19, 2018

